Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Gynecologic Cancer · Carcinoma · Uterine Cancer · Endometrial Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • O'Neal Comprehensive Cancer Center at UAB, Birmingham, Alabama, United States

    Contact: Study coordinator (Margaret Thomas, MPH) · margaretathomas@uabmc.edu
    Contact: Principal Investigator (Michael Toboni, MD)
    Rebecca Arend, MD (Sub-investigator)